Fundamental Data for WYE

WYETH(NYSE:WYE)

Wyeth is one of the world''s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company''s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

# Employees: 47426

Address: Five Giralda Farms,Madison,,USA

Phone: 973 660-5000

Fax: 973 660-5771

Website: www.wyeth.com

Email: shareowners@bankofny.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Gregory Norden (Sr. V.P.; C.F.O.)

Bernard Poussot (Presi.; C.E.O.)

Thomas Hofstaetter Ph.D (Sr. V.P.; Corp. Business Development)

John D. Feerick (Dir.)

Robert Essner (Chrmn.,)

Dividend

Ex-Dividend Date: 8/11/2009

Annual Dividend: $1.20

Current Dividend Yield: $2.44

Dividend Paid (3 months): $0.30

Indicated Dividend: N/A

Earnings

Last Earnings Date: 6/30/2009

Next Earnings Date(Expected): 10/22/2009

Mean EPS (Next Qtr): $0.78

Mean EPS (Year): $3.58

Mean Estimate(Long Term): $3.75

P/E Ratio(Based on EPS estimate): 13.730

Number of Estimates: 16

Shares Performance

Period	WYE	Compare to S&P
YTD	31.06 %	10.21 %
4 Weeks	3.06 %	1.09 %
12 Weeks	5.00 %	-6.61 %

Shares Information

Analyst Coverage: Y

Avg Volume: 14916755

Shares Outstanding: 1335M

Market Cap: $65.63B

52 Week High: $49.25

52 Week Low: $29.89

P/E Ratio: 13.850

PEG Ratio: 3.660

Split: On 5/6/1998 WYE split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 10.11 %

EPS Growth in Last Year: 7.69 %

Sales Growth in Last Quarter: 5.92 %

Sales Growth in Last Quarter: -4.21 %

Financials

Qtr Book Value: $3.15

Cash Flow/Share: $11.34

Change in Payout Ratio: -0.010

Price/Sales: -0.010